UBS Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.12M | Sell |
|
|||||
|
2025
Q2 | $2.34M | Buy |
|
|||||
|
2025
Q1 | $2.11M | Buy |
|
|||||
|
2024
Q4 | $2.87M | Buy |
|
|||||
|
2024
Q3 | $3.11M | Buy |
|
|||||
|
2024
Q2 | $2.79M | Sell |
|
|||||
|
2024
Q1 | $2.84M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $936K | Buy |
|
|||||
|
2023
Q2 | $980K | Sell |
|
|||||
|
2023
Q1 | $1.03M | Buy |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $1.17M | Sell |
|
|||||
|
2022
Q2 | $1.18M | Sell |
|
|||||
|
2022
Q1 | $1.31M | Buy |
|
|||||
|
2021
Q4 | $336K | Buy |
|
|||||
|
2021
Q3 | $90K | Buy |
|
|||||
|
2021
Q2 | $50K | Sell |
|
|||||
|
2021
Q1 | $129K | Buy |
|